News and Articles

This report was first presented at the ATTD International Conference in 2023. Background and Aims: Afon Technology is developing a wearable, non-invasive blood glucose monitor

A Welsh business is developing a potentially revolutionary way of managing diabetes after receiving funding from the world’s largest research collaboration programme. Afon Technology Ltd

A leading Welsh innovator in healthcare technology is celebrating once again after its innovative non-invasive blood glucose monitoring device received a prestigious European accolade for

The design of the world’s first non-invasive blood glucose monitoring device has won a prestigious European-wide award. A version of Afon Technology’s Glucowear triumphed in

Diabetes is a complex chronic disease that affects around 537 million people worldwide. Diabetes occurs when there is too much glucose in the blood because

Prediabetes, also known as borderline diabetes, is a condition where the sugar levels in blood are too high to be healthy, but not high enough

Afon Technology proudly announces that it has been honoured with the prestigious Peninsula Health and Safety Gold Award, highlighting the company’s outstanding dedication to health

Junkosha Award winning entry developing the world’s first wearable, non-invasive, rf/microwave  blood glucose monitoring device – winners are modernising the way blood glucose levels are

Innovative diabetes tech firm in Wales celebrates five years of success  A leading Welsh innovator in the field of diabetes technology is celebrating half a

The US Food and Drug Administration (FDA) have issued a warning regarding unapproved Diabetes technology. On February 21st 2024 the FDA released a warning about